Riverside Methodist Hospital is the largest member hospital of OhioHealth, a not-for-profit, faith-based healthcare system located in Columbus, Ohio.

There are 1,059 beds in Riverside Methodist Hospital.

During the past decade, Riverside Methodist Hospital conducted 144 clinical trials. In the 10-year time frame, 144 clinical trials started and 179 clinical trials were completed, i.e. on average, 124.3% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 66 clinical trials were completed. i.e. 188.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Riverside Methodist Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 156 trials, followed by "SWOG Cancer Research Network" with 36 trials sponsored, "Gynecologic Oncology Group" with 34 trials sponsored, "Alliance for Clinical Trials in Oncology" with 26 trials sponsored and "Boston Scientific Corporation" with 26 trials sponsored. Other sponsors include 135 different institutions and companies that sponsored additional 75 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Riverside Methodist Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 142 trials as a collaborator, "NRG Oncology" with 54 trials as a collaborator, "Canadian Cancer Trials Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 105 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "Riverside Methodist Hospital" are "Recurrent Ovarian Carcinoma" (23 trials), "Coronary Artery Disease" (17 trials), "Recurrent Fallopian Tube Carcinoma" (16 trials), "Cervical Adenocarcinoma" (15 trials) and "Recurrent Primary Peritoneal Carcinoma" (15 trials). Many other conditions were trialed in "Riverside Methodist Hospital" in a lesser frequency.

Most popular intervention types in "Riverside Methodist Hospital" are "Drug" (264 trials), "Other" (205 trials), "Biological" (125 trials), "Procedure" (73 trials) and "Device" (66 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (116 trials), "Quality-of-Life Assessment" (82 trials), "Paclitaxel" (51 trials), "Questionnaire Administration" (46 trials) and "Carboplatin" (43 trials). Other intervention names were less common.

The vast majority of trials in "Riverside Methodist Hospital" are 283 trials for "All" genders, 118 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Riverside Methodist Hospital". undefined are not yet recruiting, 58 are recruiting, 130 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 173 completed trials in Riverside Methodist Hospital, 3 suspended trials, and 31 terminated clinical trials to date.

Out of the total trials that were conducted in Riverside Methodist Hospital, 18 "Phase 1" clinical trials were conducted, 159 "Phase 2" clinical trials and 165 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 50 trials that are defined as “Not Applicable".

Riverside Methodist Hospital has several departments that took part in Clinical trials: "Riverside Methodist Hospital Cancer Care" - 135 trials, "CSC Research -- Grove City Sleep Diagnostic Center" - 2 trials